新关注 > 信息聚合 > 2015 ADA:德谷+利拉鲁肽用于透析患者更具优势

2015 ADA:德谷+利拉鲁肽用于透析患者更具优势

ADA 2015: de Gu + liraglutide for dialysis patients more advantage

2015-06-11 16:21:19来源: 丁香园

来自日本长崎 Renal Center 的 Funakoshi 博士在第 75 届美国糖尿病协会(ADA)科学年会报告了一项最新研究结果:德谷胰岛素+利拉鲁肽(IDeg+Lira)用于血糖控制不佳的...

from Dr. funakoshi Nagasaki renal center in Japan in the year of the 75th session of the American Diabetes Association (ADA) science will report the results of a new study: German Valley insulin + liraglutide IDeg+ lira for poor glycemic control.